Stada Pharmsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-11-29
Share capital
1 057 400,00 PLN
Activity description

Walmark makes dietary supplements with vitamins, minerals and herbal extracts, plus products for kids, female health, male health, joint health, gut health and respiratory health. It operates across Central and Eastern Europe, is headquartered in the Czech Republic, and sells in more than 40 countries. Its portfolio includes over 650 products.

Registered address
ul. Krakowiaków 44, 02-255 Warszawa, Poland
Website
walmark.euWebsite active
Email
Email address current
Social media
Electronic delivery address
AE:PL-17618-14480-HIBCF-16

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 98.07mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 271.19kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 87.74mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 58.45mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2003-10-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jan 12, 2024Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Bartosz Bobrzyk — Attorney-in-fact (joint)
Christos Gallis — Management Board Member
Ričardas Gražulis — Management Board Member
Kacper Kubisiak — Attorney-in-fact (joint)

Manner of representation

If the management board is a one-person management board, a member of the management board acting independently is authorized to represent the company. If the management board is a multi-member management board, two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company.

Ownership

OwnerSharesShare valueStake
Stada Arzneimittel Ag
311$285,629.39100%

Beneficial owners

PersonRights
Christos Gallis (64)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Ricardas Grazulis (50)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

NameRevenueWebsite
Colgate-Palmolive (Poland)sp. z o.o.$227,982,169.76colgatepalmolive.com
Przedsiębiorstwo Przemysłowo Handlowe Stanlabsp. z o.o.$84,801,569.58stanlab.eu
Publimar Marek Pińkowskisp. k.$65,637,878.31publimar.pl
UPL Polskasp. z o.o.$64,518,791.19upl-ltd.pl
PolcanS.K.A.$45,083,698.55polcan.pl
Orkla CareS.A.$43,777,691.06orklacare.com.pl
WKsp. z o.o.$43,406,615.98wksklep.pl
Orecosp. z o.o.$41,721,386.61oreco.pl
Martinsp. j.$40,600,390.98martin-zawiercie.eu
APS Marcin WalasekS.K.A.$37,508,581.19dentaltree.pl

Change history

DateEvent
2024-01-03Share capital change (1,054,000.00 PLN → 1,057,400.00 PLN)
2021-03-26Address change (Teatralna 9, 41-200, Sosnowiec → Ul. Krakowiaków 44, 02-255, Warszawa)
2021-03-26Name change (Walmark → Stada Pharm)
2003-02-17Share capital change (51,000.00 PLN → 1,054,000.00 PLN)
2001-11-29Entered in the register

FAQ

Last updated: 2026-05-20